Detalhe da pesquisa
1.
The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry.
Future Oncol
; 14(26): 2713-2723, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30207489
2.
The role of miRNAs in mast cells and other innate immune cells.
Immunol Rev
; 253(1): 12-24, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-23550635
3.
Clinical presentation and management practice of systemic mastocytosis. A survey on 460 Italian patients.
Am J Hematol
; 91(7): 692-9, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27060898
4.
Narrow-band UVB phototherapy and psoralen-ultraviolet A photochemotherapy in the treatment of cutaneous mastocytosis: a study in 20 patients.
Photodermatol Photoimmunol Photomed
; 32(5-6): 238-246, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-27353865
5.
Reduced DNA methylation and hydroxymethylation in patients with systemic mastocytosis.
Eur J Haematol
; 95(6): 566-75, 2015 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25688802
6.
The Circulating Level of Soluble Receptor for Advanced Glycation End Products Displays Different Patterns in Ulcerative Colitis and Crohn's Disease: A Cross-Sectional Study.
Dig Dis Sci
; 60(8): 2327-37, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-25757448
7.
Long term outcome of Ph+ CML patients achieving complete cytogenetic remission with interferon based therapy moving from interferon to imatinib era.
Am J Hematol
; 89(2): 119-24, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24122886
8.
Philadelphia-positive patients who already harbor imatinib-resistant Bcr-Abl kinase domain mutations have a higher likelihood of developing additional mutations associated with resistance to second- or third-line tyrosine kinase inhibitors.
Blood
; 114(10): 2168-71, 2009 Sep 03.
Artigo
Inglês
| MEDLINE | ID: mdl-19589924
9.
The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up.
Haematologica
; 94(2): 205-12, 2009 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-19144656
10.
The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives.
J Allergy Clin Immunol Pract
; 7(1): 81-87, 2019 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30416055
11.
International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study.
Lancet Haematol
; 6(12): e638-e649, 2019 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-31676322
12.
The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study.
Haematologica
; 92(9): 1173-9, 2007 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-17666373
13.
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients.
Clin Cancer Res
; 12(10): 3037-42, 2006 May 15.
Artigo
Inglês
| MEDLINE | ID: mdl-16707599
14.
'Real-life' study of imatinib therapy in chronic phase-chronic myeloid leukemia: A novel retrospective observational longitudinal analysis.
Hematology
; 22(1): 1-8, 2017 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-27320082
15.
Outcome of four patients with chronic myeloid leukemia after imatinib mesylate discontinuation.
Haematologica
; 90(7): 979-81, 2005 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-15996937
16.
TP53 codon 72 polymorphism in patients with chronic myeloid leukemia.
Haematologica
; 89(7): 868-9, 2004 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-15257943
17.
Hypereosinophilic syndrome and cyclic oscillations in blood cell counts. A clonal disorder of hematopoiesis originating in a pluripotent stem cell.
Haematologica
; 89(4): 497-9, 2004 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-15075087
18.
The development of peripheral T-cell lymphoma after successful treatment for diffuse large B-cell lymphoma in a patient with suspected adult onset immunodeficiency: more questions than answers?
BMJ Case Rep
; 20132013 Dec 16.
Artigo
Inglês
| MEDLINE | ID: mdl-24343800
19.
First case of an AIDS patient with systemic mast cell disease associated with FIP1-positive eosinophilia treated with imatinib mesylate therapy.
J Clin Oncol
; 24(4): e6-7, 2006 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-16446324